The permanence of memory has long fascinated neuroscientists, who recognize that engrams—the physical substrates of memories—are formed by the recruitment of excitatory principal neurons. However, the role of inhibitory neurons in modulating these memory traces, particularly the nature of their participation in determining whether a memory becomes stable or remains malleable, has remained elusive. This fresh investigation explores how a specific subset of GABAergic interneurons expressing NPY modulates this critical balance, revealing mechanisms that toggle memory states during fear extinction learning in mice.

Central to this process is the ventral CA1 (vCA1) hippocampal area, a brain locus renowned for its crucial involvement in emotional memory processing and fear response regulation. The authors introduce compelling evidence demonstrating that NPY+ GABAergic interneurons in the vCA1 enact a twofold inhibitory strategy: a rapid GABA-dependent suppression facilitating the acquisition phase of memory, and a more prolonged, slower inhibition mediated through the release of NPY itself, which progressively promotes memory extinction.

The study’s experimental approach combined cutting-edge calcium imaging techniques with behavioral analyses in male mice subjected to well-established paradigms of cued fear conditioning and extinction. As extinction learning advanced and the mice transitioned from a ‘fear-on’ to a ‘fear-off’ state, the researchers documented a pronounced ramping up in both calcium signals within the NPY+ interneurons and local NPY release. This correlation underpins the critical role of these interneurons not simply as passive modulators but as active agents that pivot the brain’s circuitry to favor memory flexibility.

Intriguingly, the slow-acting peptidergic inhibition through NPY is selectively funneled through two nonoverlapping populations of principal neurons distinguished by their expression of neuropeptide Y receptors 1 and 2 (NPY1R and NPY2R, respectively). This segregation underlies a sophisticated gating mechanism in which NPY1R-expressing cells dominate regulation during the early, rapid extinction stage, while the NPY2R-expressing neurons orchestrate later-stage slower modulation, effectively managing memory stability.

The distinction between the roles of these receptor-expressing neuron groups not only challenges prior models that treated inhibitory regulation as homogeneous but also opens new avenues to understand how memory dynamics can be precisely tuned on temporal scales. This spatial and functional stratification achieves a delicate balance: facilitating initial forgetting or suppression of fear memories while eventually consolidating the extinction process, thereby preventing inappropriate or excessive erasure of learned information.

At the molecular level, NPY acts as a neuromodulator released by the interneurons in addition to classical fast neurotransmitters such as GABA. This dual-functionality highlights the remarkable versatility of inhibitory neurons in modulating synaptic transmission. Whereas GABA provides immediate, phasic inhibition to shape neuronal firing patterns during memory formation, the neuropeptide exerts a modulatory influence that unfolds over longer timescales, adjusting network excitability to promote memory adaptation and emotional resilience.

This discovery of temporally distinct inhibitory processes driven by the same cell type amplifies understanding of how neurochemical signaling coordinates complex behavioral states. The NPY system’s capacity to slant the network balance suggests a finely engineered feedback loop where interneurons dynamically adjust the emotional valence of memories, potentially defending against maladaptive persistence of fear responses seen in anxiety disorders and PTSD.

The implications of these findings extend beyond basic neuroscience and carry translational potential. By manipulating NPY signaling pathways or receptor-specific targets within the hippocampus, novel therapeutic strategies could be devised to selectively enhance extinction learning—critical in clinical contexts where pathological fear memories undermine mental health. Importantly, the ability to differentially modulate early versus late extinction phases could allow refined interventions designed to recalibrate memory stability with precision.

Furthermore, this research resonates with broader themes in neurobiology regarding how peptidergic systems co-opt excitatory ensembles to regulate cognition and behavior. The dual inhibitory role of NPY+ interneurons exemplifies how the brain achieves a balance between plasticity and stability—essentially deciding when a memory becomes fixed versus when it remains open to updating and modification.

Another notable aspect is the innovative use of genetically encoded calcium indicators to track activity within interneuron subpopulations during live behavior. This methodological advance not only corroborates causality but enables the dissection of neural circuit dynamics at unprecedented resolution, strengthening links between specific cellular phenotypes and complex behavioral outcomes.

While this study focused on cued fear extinction in male mice, its implications potentially extend to other forms of learning and memory across sexes and species. Given the conserved nature of NPY and its receptors, similar inhibitory mechanisms might be involved in diverse cognitive processes and neuropsychiatric conditions, broadening the scope of future research.

This work also prompts reconsideration of inhibitory neuron classification schemes, suggesting that peptidergic content and receptor-specific signaling pathways define specialized subtypes beyond traditional markers. NPY+ interneurons emerge as critical nodes that interface fast synaptic inhibition with slower neuropeptide modulation, a duality that may exemplify how the brain fine-tunes circuit function to balance behavioral flexibility with memory integrity.

In conclusion, Wu et al. present compelling evidence that a subtype-specific population of NPY-expressing interneurons in the ventral CA1 hippocampus orchestrates the mechanisms of memory lability and stability through temporally distinct inhibitory pathways. This discovery not only advances understanding of fear memory processing but also provides a conceptual framework for unraveling how neural circuits integrate fast neurotransmitter and slow neuromodulator signaling to shape behavior adaptively.

As future investigations further decode these peptidergic inhibitory dynamics, the potential for targeted modulation of memory processes opens exciting prospects for treating fear-related psychopathologies and enhancing cognitive adaptability. This landmark study redefines how memory traces are sculpted by interneuron subtypes, highlighting the nuanced interplay of neuropeptides and classical neurotransmitters in orchestrating the brain’s most fundamental functions.

Subject of Research: Neuropeptide Y-mediated regulation of memory acquisition and extinction in ventral hippocampal interneurons.

Article Title: Neuropeptide Y co-opts neuronal ensembles for memory lability and stability.

Article References:
Wu, YJ., Gu, X., Kong, Y. et al. Neuropeptide Y co-opts neuronal ensembles for memory lability and stability. Nat Neurosci (2026). https://doi.org/10.1038/s41593-026-02235-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41593-026-02235-x

Keywords: Neuropeptide Y, memory extinction, ventral CA1, interneurons, fear conditioning, GABAergic inhibition, NPY receptors, neural circuits, memory lability, memory stability

The core of this discovery lies in the role of the basal amygdala (BA), a central hub in the brain implicated in processing and regulating fear memories. In typical brains, exposure to traumatic events prompts increased synaptic complexity and heightened excitability of excitatory neurons within the BA. This chain of neural activity facilitates the extinction of fear memories, effectively “erasing” maladaptive responses over time. However, in mice harboring a human ASD-associated mutation in Grin2b—a gene encoding the GluN2B subunit of NMDA receptors—this adaptive mechanism is profoundly altered. Despite forming fear memories normally, these mutant animals fail to extinguish them, resulting in persistent and enhanced long-term fear reminiscent of PTSD pathology.

Electrophysiological analyses provided a window into the cellular deficits underpinning this phenomenon. Following traumatic stimuli, BA excitatory neurons in Grin2b-mutant mice displayed suppressed synaptic transmission and a marked reduction in neuronal excitability. These changes indicate a silencing of the amygdalar network precisely when heightened activity would be necessary to overwrite fear memories. The failure to activate these circuits effectively “locks in” the traumatic experience, preventing the natural attenuation of fear responses and perpetuating chronic anxiety.

Importantly, the study employed chemogenetics—a cutting-edge technique that allows selective modulation of neuronal activity via engineered receptors responsive to designer drugs—to assess causality in this process. By artificially stimulating the BA excitatory neurons during extinction learning, researchers successfully restored synaptic activity and neuron excitability. This targeted reactivation not only normalized neural signaling but also rescued behavioral deficits, enabling mice to extinguish fear memories and diminish pathological fear responses. Such evidence underscores the centrality of amygdalar dysfunction in ASD-related PTSD vulnerability and opens avenues for therapeutic intervention.

These results offer a mechanistic explanation for clinical observations where individuals with autism report exaggerated and enduring fear or anxiety, often mirroring PTSD symptomatology. Until now, the convergence of ASD and trauma-related disorders has been poorly understood at the circuit and molecular levels, with much reliance on patient self-reports and epidemiological associations. The IBS team’s approach reveals a direct link between Grin2b mutation-induced receptor dysfunction, altered synaptic physiology in the amygdala, and disrupted fear-memory processing, bridging a critical knowledge gap.

Professor Kim elaborates that these findings illuminate why amygdalar hypoactivity, rather than hyperactivity, can underlie PTSD-like phenotypes in this autism model. While excessive amygdala activation has traditionally been associated with anxiety disorders, here the silencing of key excitatory neurons presents an alternative pathophysiological mechanism. This insight challenges previous models and suggests that effective treatments might need to strategically enhance amygdalar excitability rather than suppress it.

To ensure robustness, the research team meticulously controlled for potential confounds, verifying that viral vectors used for chemogenetic manipulation did not introduce artifacts affecting neuronal function. Cross-disciplinary collaboration aided in precisely identifying the BA as the pivotal brain region implicated. This comprehensive approach strengthens the validity of the conclusions and provides a solid foundation for translational applications.

Looking ahead, the researchers plan to integrate transcriptomic and proteomic analyses to map molecular changes within BA excitatory neurons after trauma exposure. Such investigations will help identify specific gene expression profiles and signaling pathways influenced by Grin2b mutations, offering further insight into the molecular cascade driving synaptic and functional alterations. Additionally, pharmacological studies targeting GluN2B-containing NMDA receptors with selective agonists or antagonists aim to delineate receptor-specific roles in fear memory regulation.

This pioneering work not only deepens our understanding of fear-memory extinction mechanisms in the context of autism but also highlights potential therapeutic targets. Reactivating silenced amygdala circuits may prove a viable strategy to mitigate PTSD-like symptoms in individuals with ASD, addressing a critical unmet need in clinical management. The ability to reverse behavioral and physiological deficits in a mouse model through targeted neuronal stimulation carries profound implications for future clinical therapies.

In sum, the study represents a major advance in neuroscience, synthesizing molecular genetics, electrophysiology, and chemogenetics to unravel a complex neuropsychiatric phenomenon. By detailing how a single gene mutation disrupts neuronal networks responsible for fear extinction, it sets the stage for novel approaches to treat anxiety and trauma-related disorders in autism. This work not only bridges gaps in fundamental science but also offers hope for interventions improving quality of life for millions affected by these intertwined conditions.

As Professor Kim reflects, this research underscores the transformative potential of mechanistic investigation in mental health. “By moving beyond descriptive symptoms to causative pathways, we can forge new therapeutic avenues where none existed before.” The confluence of genetics, circuit biology, and behavioral neuroscience promises to redefine our understanding of fear, memory, and resilience in autism spectrum disorder.

Subject of Research: Neural mechanisms underlying PTSD-like symptoms in autism spectrum disorder caused by Grin2b mutations affecting basal amygdala neuronal function.

Article Title: Grin2b-mutant mice exhibit heightened remote fear via suppressed extinction and chronic amygdalar synaptic and neuronal dysfunction

News Publication Date: 17-Sep-2025

Web References:
http://dx.doi.org/10.1126/sciadv.adr7691

Image Credits: Institute for Basic Science

Keywords: Autism, Developmental disabilities, Post traumatic stress disorder, Amygdala, Fear, Excitatory synapses, Neuronal synapses, Neurons, Brain structure, Psychiatric disorders, Clinical psychology, Central nervous system